Actively Recruiting
Assessment of Disease Burden in Hairy Cell Leukemia
Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2025-01-17
45
Participants Needed
1
Research Sites
43 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Drug-free, single-center, prospective observational pilot study in hairy Cell Leukemia patients
CONDITIONS
Official Title
Assessment of Disease Burden in Hairy Cell Leukemia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Histologically confirmed diagnosis of Hairy Cell Leukemia
- Newly diagnosed and candidates for first-line treatment with purine analogues
- In relapse after previous treatment with indication for rescue therapy, excluding splenectomy
- In complete remission for at least 5 years after first-line treatment without signs of relapse or need for new therapy
- Age 18 years or older at enrollment
- Signed written informed consent
You will not qualify if you...
- Presence of a second active malignancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
IRCCS Azienda Ospedaliero - Universitaria di Bologna
Bologna, Bologna, Italy, 40138
Actively Recruiting
Research Team
P
Pier Luigi Zinzani, MD
CONTACT
A
Alessandro Broccoli, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
PREVENTION
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here